Please use this identifier to cite or link to this item:
Title: Feasibility and acceptability of using wireless cardiac monitoring before transcatheter aortic valve implantation (TAVI): A pilot study.
Epworth Authors: Lee, C
Hutchinson, Anastasia
Dick, Ronald
Yudi, Matias
Proimos, George
Soon, Kean
Palmer, Sonny
Leary, Olivia
Canon, Candice
Khaw, Damien
Walton, Antony
Keywords: Transcatheter Aortic Valve Implantation
Remote Cardiac Monitoring
CardioScan "mypatch" Holter monitor
Cardiac Sciences Clinical Institute
Issue Date: Oct-2023
Conference Name: Epworth HealthCare Research Month 2023
Conference Location: Epworth Research Institute, Victoria, Australia
Abstract: Currently, all transcatheter aortic valve implantation (TAVI) patients treated at Epworth Richmond are admitted the day before their procedure for cardiac monitoring to identify undiagnosed arrhythmias that may increase the risk of requiring a permanent pacemaker. These patients also undergo a routine pre operative full blood test, chest X Ray and ECG. Use of remote cardiac monitoring devices from the patient’s home may increase the efficiency of workflows, reduce bed usage in coronary care, and improve bed capacity, ultimately increasing hospital revenue. However, presently, the use of such devices has been inadequately tested. If the data quality meets the requirements of treating interventional cardiologists, this could potentially eliminate the need for patients to be admitted 24 hours prior to their scheduled TAVI procedure.
Type: Conference Poster
Affiliated Organisations: Centre for Quality and patient Safety Research, Deakin-Epworth HealthCare Partnership
Type of Clinical Study or Trial: Pilot Study
Appears in Collections:Research Month

Files in This Item:
File Description SizeFormat  
Research Month 2023 - Poster presentation_Diana Lee.pdf489.87 kBAdobe PDFThumbnail

Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.